<p>The Serum Institute of India (SII), which manufactures AstraZeneca and Oxford University's Covid-19 vaccine — Covishield, has sought indemnity protection against liabilities, news agency <em>ANI </em><a href="https://twitter.com/ANI/status/1400286080084058112" target="_blank">reported</a> citing sources familiar with the matter.</p>.<p>ANI on Wednesday reported that Pfizer and Moderna were a step closer to indemnity deals with the government of India.</p>.<p>The pharma giants had sought from the government indemnity from costs relating to severe vaccine side-effects. India's apex drug regulator has also waived the requirement of testing every batch of foreign-made Covid-19 vaccines and conducting bridging trials for vaccines approved by the WHO.</p>.<p><br /><strong>More details awaited.</strong></p>
<p>The Serum Institute of India (SII), which manufactures AstraZeneca and Oxford University's Covid-19 vaccine — Covishield, has sought indemnity protection against liabilities, news agency <em>ANI </em><a href="https://twitter.com/ANI/status/1400286080084058112" target="_blank">reported</a> citing sources familiar with the matter.</p>.<p>ANI on Wednesday reported that Pfizer and Moderna were a step closer to indemnity deals with the government of India.</p>.<p>The pharma giants had sought from the government indemnity from costs relating to severe vaccine side-effects. India's apex drug regulator has also waived the requirement of testing every batch of foreign-made Covid-19 vaccines and conducting bridging trials for vaccines approved by the WHO.</p>.<p><br /><strong>More details awaited.</strong></p>